UMIN ID: UMIN000056867
Registered date:30/01/2025
Exploratory Study on the Effect of Food Ingredient Intake on Postprandial Blood Glucose Levels -Open-Label Crossover Study-
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Not applicable |
Date of first enrollment | 2025/01/31 |
Target sample size | 24 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. |
Outcome(s)
Primary Outcome | Cmax of blood glucose |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 30years-old |
---|---|
Age maximum | 64years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | (1) Subjects who regularly consume pharmaceuticals or quasi-drugs that may affect the efficacy evaluation of the test food (2) Subjects who continuously consume food for specified health use, functional foods, or health foods that may affect the efficacy evaluation of the test food (3) Subjects whose lifestyle is scheduled to change drastically before or after the start of the study (including business trip, travel, etc. that will significantly change the rhythm of their daily life) (4) Subjects who are currently participating in other studies, who have participated in other studies within 4 weeks after their completion, or who are planning to participate in other studies during the study period (except for the specific studies) (5) Other subjects who are judged by the investigator as unsuitable for the study |
Related Information
Primary Sponsor | Apoplus Station Co.,Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Kanamori Giken Co., Ltd. |
Secondary ID(s) |
Contact
public contact | |
Name | Ryoko Koizumi |
Address | 2-14-1, Nihonbashi, Chuo-ku, Tokyo, 103-0027, JAPAN Japan 103-0027 |
Telephone | 03-6777-7789 |
food-contact@apoplus.co.jp | |
Affiliation | Apoplus Station Co., Ltd. CRO Department Clinical Operations Division |
scientific contact | |
Name | Tadashi Watanabe |
Address | 1-5-16, Haneda, Ota-ku, Tokyo, 144-0043, JAPAN Japan |
Telephone | 03-3741-0223 |
wnb.cto@gmail.com | |
Affiliation | Watanabe Hospital Surgery |